OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Benefit, recurrence pattern, and toxicity to adjuvant anti-PD-1 monotherapy varies by ethnicity and melanoma subtype: An international multicenter cohort study
Xue Bai, Aleigha Lawless, Juliane A. Czapla, et al.
JAAD International (2024) Vol. 15, pp. 105-114
Open Access | Times Cited: 8
Xue Bai, Aleigha Lawless, Juliane A. Czapla, et al.
JAAD International (2024) Vol. 15, pp. 105-114
Open Access | Times Cited: 8
Showing 8 citing articles:
Significance of PAI-1 on the development of skin cancer: optimal targets for cancer therapies
Taku Fujimura
Biomedical Journal (2025), pp. 100850-100850
Open Access
Taku Fujimura
Biomedical Journal (2025), pp. 100850-100850
Open Access
Adjuvant Anti–PD-1 Monotherapy Versus Observation for Stage III Acral Melanoma of the Sole: A Multicenter Retrospective Study in Japanese Patients
Shigeru Koizumi, Naoya Yamazaki, Yuki Ichigozaki, et al.
JCO Global Oncology (2025), Iss. 11
Open Access
Shigeru Koizumi, Naoya Yamazaki, Yuki Ichigozaki, et al.
JCO Global Oncology (2025), Iss. 11
Open Access
The Evaluation of Immune Checkpoint Inhibitors and BRAF/MEK Inhibitors in Different Therapy Lines for Metastatic Melanoma: A Retrospective Study
Saki Okuda-Hiwatashi, Ryo Amagai, Taku Fujimura, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 18, pp. 5560-5560
Open Access | Times Cited: 3
Saki Okuda-Hiwatashi, Ryo Amagai, Taku Fujimura, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 18, pp. 5560-5560
Open Access | Times Cited: 3
Effectiveness of immune checkpoint inhibitors and other treatment modalities in patients with advanced mucosal melanomas: a systematic review and individual patient data meta-analysis
Andrea York Tiang Teo, Chun En Yau, Chen Ee Low, et al.
EClinicalMedicine (2024) Vol. 77, pp. 102870-102870
Open Access | Times Cited: 2
Andrea York Tiang Teo, Chun En Yau, Chen Ee Low, et al.
EClinicalMedicine (2024) Vol. 77, pp. 102870-102870
Open Access | Times Cited: 2
Three-Year Analysis of Adjuvant Therapy in Postoperative Melanoma including Acral and Mucosal Subtypes
Yusuke Muto, Yumi Kambayashi, Hiroshi Kato, et al.
Cancers (2024) Vol. 16, Iss. 15, pp. 2755-2755
Open Access | Times Cited: 1
Yusuke Muto, Yumi Kambayashi, Hiroshi Kato, et al.
Cancers (2024) Vol. 16, Iss. 15, pp. 2755-2755
Open Access | Times Cited: 1
This Month in JAAD International: July 2024
Jonathan Kantor
Journal of the American Academy of Dermatology (2024) Vol. 91, Iss. 1, pp. 28-28
Closed Access
Jonathan Kantor
Journal of the American Academy of Dermatology (2024) Vol. 91, Iss. 1, pp. 28-28
Closed Access
Clinicopathologic Features and Surgical Management in Vulvovaginal Melanoma – A Retrospective Single Center Study
Telma Lumiala, Virve Koljonen, Kaisu Ojala
Journal of Plastic Reconstructive & Aesthetic Surgery (2024) Vol. 100, pp. 8-15
Closed Access
Telma Lumiala, Virve Koljonen, Kaisu Ojala
Journal of Plastic Reconstructive & Aesthetic Surgery (2024) Vol. 100, pp. 8-15
Closed Access
Adjuvant and neoadjuvant immunotherapy for acral and mucosal melanoma
Takaya Komori, Shigeru Koizumi, Soki Inoue, et al.
EJC Skin Cancer (2024), pp. 100277-100277
Closed Access
Takaya Komori, Shigeru Koizumi, Soki Inoue, et al.
EJC Skin Cancer (2024), pp. 100277-100277
Closed Access
